quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:15:07·37d
INSIDERFiling
Takeda Pharmaceutical Company Limited logo

SEC Form 3 filed by Takeda Pharmaceutical Company Limited

TAK· Takeda Pharmaceutical Company Limited
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • TAK
    Takeda Pharmaceutical Company Limited
    Health Care

Recent analyst ratings

  • Apr 8UpdateBernstein-
  • Jan 13UpdateMorgan Stanley-
  • Apr 2UpdateMorgan Stanley-
  • Mar 16UpdateBofA Securities$20.00
  • Jul 19UpdateCowen$24.00
  • Oct 7UpdateMorgan Stanley-

Related

  • ANALYST16d
    Takeda Pharma upgraded by Bernstein
  • INSIDER18d
    SEC Form 3 filed by new insider Greenway Nicola Deidre Petal
  • INSIDER18d
    SEC Form 3 filed by new insider Farajallah Awny Samaan Botros
  • INSIDER18d
    SEC Form 3 filed by new insider Ibrahim Ramy Riad Ahmed
  • PR24d
    Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
  • SEC25d
    SEC Form 6-K filed by Takeda Pharmaceutical Company Limited
  • PR26d
    Takeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
  • SEC29d
    SEC Form 6-K filed by Takeda Pharmaceutical Company Limited
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022